Qwen 3.8 Max Launches with a Massive 2.44 Trillion Parameters

Qwen 3.8 Max brings 2.44 trillion parameters to the open-weight AI landscape. See how this new multimodal powerhouse handles ...
ET CIO

10 Best Open-Source Vulnerability Scanners for Budget-Conscious CIOs in 2026

Discover the best open-source vulnerability scanners of 2026 that help CIOs minimize security costs while ensuring robust protection against software vulnerabilities. Learn about their features and ...

Roche Advances AI-Derived Drug Target With Partner Recursion

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an ...
pharmaphorum

Company Profile: Recursion

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...